256 related articles for article (PubMed ID: 29570708)
1. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.
Busger Op Vollenbroek FTM; Doggen CJM; Janssens RWA; Bernelot Moens HJ
PLoS One; 2018; 13(3):e0194401. PubMed ID: 29570708
[TBL] [Abstract][Full Text] [Related]
2. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
3. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
5. [Long-term survival of methotrexate in psoriatic arthritis].
Ricci M; De Marco G; Desiati F; Mazzocchi D; Rotunno L; Battafarano N; Marchesoni A
Reumatismo; 2009; 61(2):125-31. PubMed ID: 19633799
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients.
Wollina U; Ständer K; Barta U
Clin Rheumatol; 2001; 20(6):406-10. PubMed ID: 11771523
[TBL] [Abstract][Full Text] [Related]
7. Alefacept with methotrexate for treatment of psoriatic arthritis: open-label extension of a randomized, double-blind, placebo-controlled study.
Mease PJ; Reich K;
J Am Acad Dermatol; 2009 Mar; 60(3):402-11. PubMed ID: 19028407
[TBL] [Abstract][Full Text] [Related]
8. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Boyce EG; Halilovic J; Stan-Ugbene O
Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
Spadaro A; Riccieri V; Sili-Scavalli A; Sensi F; Taccari E; Zoppini A
Clin Exp Rheumatol; 1995; 13(5):589-93. PubMed ID: 8575136
[TBL] [Abstract][Full Text] [Related]
10. Leflunomide in psoriatic arthritis: a retrospective study of discontinuation rate in daily clinical practice compared with methotrexate.
Malesci D; Tirri R; Buono R; La Montagna G
Clin Exp Rheumatol; 2007; 25(6):881-4. PubMed ID: 18173924
[TBL] [Abstract][Full Text] [Related]
11. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
13. The effect of low dose methotrexate on bone density.
Cranney AB; McKendry RJ; Wells GA; Ooi DS; Kanigsberg ND; Kraag GR; Smith CD
J Rheumatol; 2001 Nov; 28(11):2395-9. PubMed ID: 11708409
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate in psoriatic arthritis.
Cutolo M; Seriolo B; Pizzorni C; Craviotto C; Sulli A
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S76-80. PubMed ID: 12463453
[TBL] [Abstract][Full Text] [Related]
15. The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study.
Fagerli KM; Lie E; van der Heijde D; Heiberg MS; Lexberg AS; Rødevand E; Kalstad S; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2014 Jan; 73(1):132-7. PubMed ID: 23291385
[TBL] [Abstract][Full Text] [Related]
16. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
al-Awadhi A; Dale P; McKendry RJ
J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
[TBL] [Abstract][Full Text] [Related]
17. Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort.
Nikiphorou E; Negoescu A; Fitzpatrick JD; Goudie CT; Badcock A; Östör AJ; Malaviya AP
Clin Rheumatol; 2014 May; 33(5):609-14. PubMed ID: 24609758
[TBL] [Abstract][Full Text] [Related]
18. Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis.
Zargari O; Hejazi S; Shahidi-Dadras M; Younespour S; Robati R; Firooz A; Toosi P; Feldman SR
Int J Dermatol; 2014 Mar; 53(3):385-9. PubMed ID: 24134730
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics.
Mease PJ; Gladman DD; Papp KA; Khraishi MM; Thaçi D; Behrens F; Northington R; Fuiman J; Bananis E; Boggs R; Alvarez D
J Am Acad Dermatol; 2013 Nov; 69(5):729-735. PubMed ID: 23981683
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of psoriasis with biologics: a survey of dermatological and rheumatological practice at Reims University Hospital].
Adnot-Desanlis L; Brochot P; Eschard JP; Bernard P; Reguiaï Z
Ann Dermatol Venereol; 2012 May; 139(5):355-62. PubMed ID: 22578339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
